SciELO - Scientific Electronic Library Online

 
vol.26 suppl.3Preventive and nutritional factors of osteoporosisRole of hormone replacement therapy in the prevention and treatment of menopausal osteoporosis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Anales del Sistema Sanitario de Navarra

Print version ISSN 1137-6627

Abstract

LOZA, E.. Treatment of postmenopausal osteoporosis. Anales Sis San Navarra [online]. 2003, vol.26, suppl.3, pp.91-98. ISSN 1137-6627.

Prevention and treatment of osteoporosis consists of non-drug and drug therapy. This review of the topic will provide an overview of the approach to therapy of osteoporosis in postmenopausal women. In the past, estrogen replacement was considered a primary therapy for the prevention of postmenopausal osteoporosis. However, data from the Women´s Health Initiative (WHI) revealed that estrogen-progestine therapy does not reduce the risk of coronary heart disease, and increases the risk of breast cancer, stroke, and venous thromboembolic events. As a result of these findings, other antiresorptive agents are now the drugs of choice for the prevention and treatment of osteoporosis in postmenopausal women.

Keywords : Postmenopausal osteoporosis; Treatment; Bisphosphonates; Raloxifene; Calcitonin.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License